Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Evexia LifecareBOM:524444 -3.05%64 Piotroski F-Score is 6 as of Jul. 27, 2026, which is at its 10-year median of 6.00. GuruFocus rates BOM:524444 with a GF Score™ of 64/100 and a GF Value™ of ₹1.59 (Fairly Valued). The stock has 5 warning signs investors should review. Among 1,912 Consumer Packaged Goods companies, Evexia Lifecare ranks better than 73.33% on this metric.
The zones of discrimination were as such:
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Evexia Lifecare has an F-score of 6 indicating the company's financial situation is typical for a stable company.
The historical rank and industry rank for Evexia Lifecare's Piotroski F-Score or its related term are showing as below:
BOM:524444'
s Piotroski F-Score Range Over the Past 10 Years
Min: 2 Med: 6 Max: 8
Current: 6
During the past 13 years, the highest Piotroski F-Score of Evexia Lifecare was 8. The lowest was 2. And the median was 6.
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
Evexia Lifecare Piotroski F-Score Related Terms
Evexia Lifecare Piotroski F-Score Historical Data
* Premium members only.
The historical data trend for Evexia Lifecare's Piotroski F-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:524444 vs KHC, GIS: Piotroski F-Score Comparison
For the Packaged Foods subindustry, Evexia Lifecare's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Evexia Lifecare Piotroski F-Score vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Evexia Lifecare's Piotroski F-Score distribution charts can be found below:
* The bar in red indicates where Evexia Lifecare's Piotroski F-Score falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Evexia Lifecare's current Net Income (TTM) was 16.
==> Positive ==> Score 1.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
Evexia Lifecare's return on assets of this year was 0.00181254. Evexia Lifecare's return on assets of last year was 0.00046716.
==> This year is higher. ==> Score 1.
Question 4. Quality of Earnings (Accrual)
Compare Cash flow return on assets (2) to return on assets (1)
Evexia Lifecare's gearing of this year was 0.00049719. Evexia Lifecare's gearing of last year was 0.42139455.
==> This year is lower or equal to last year. ==> Score 1.
Question 6. Change in Working Capital (Liquidity)
Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.
Score 1 if this year's current ratio is higher, 0 if it's lower
Evexia Lifecare's current ratio of this year was 1.39072966. Evexia Lifecare's current ratio of last year was 1.66336104.
==> Last year's current ratio is higher ==> Score 0.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
Evexia Lifecare's number of shares in issue this year was 2026.625. Evexia Lifecare's number of shares in issue last year was 2062.5.
==> There is smaller number of shares in issue this year, or the same. ==> Score 1.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
Evexia Lifecare's gross margin of this year was 0.05211335. Evexia Lifecare's gross margin of last year was 0.04435365.
==> This year's gross margin is higher. ==> Score 1.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
Evexia Lifecare's asset turnover of this year was 0.12328233. Evexia Lifecare's asset turnover of last year was 0.09806404.
==> This year's asset turnover is higher. ==> Score 1.
Evaluation
Piotroski F-Score
=
Que. 1
+
Que. 2
+
Que. 3
+
Que. 4
+
Que. 5
+
Que. 6
+
Que. 7
+
Que. 8
+
Que. 9
=
1
+
0
+
1
+
0
+
1
+
0
+
1
+
1
+
1
=
6
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Evexia Lifecare has an F-score of 6 indicating the company's financial situation is typical for a stable company.
Evexia Lifecare (BOM:524444) has a Piotroski F-Score of 6 as of Jul. 27, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Evexia Lifecare and its competitors. This is near median its historical median of 6.00. Over the past decade, Evexia Lifecare's Piotroski F-Score has ranged from 2.00 to 8.00. According to the industry distribution chart, Evexia Lifecare ranks #510 out of 1912 companies in the Consumer Packaged Goods industry, placing it in the top 26.7%.
Is Evexia Lifecare's Piotroski F-Score too high?
Evexia Lifecare's current Piotroski F-Score of 6 is near median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 8.00. The Consumer Packaged Goods industry median Piotroski F-Score is 5.00. Evexia Lifecare's value of 6 is 20% above this industry median. Based on the distribution chart, Evexia Lifecare ranks #510 out of 1912 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Evexia Lifecare has a GF Score™ of 64/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Evexia Lifecare's Piotroski F-Score compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Evexia Lifecare ranks #510 out of 1912 companies for Piotroski F-Score. This puts Evexia Lifecare in the upper half of its industry. The industry median Piotroski F-Score is 5.00. Evexia Lifecare's value of 6 is 20% above this benchmark. Historically, Evexia Lifecare's own Piotroski F-Score has ranged from 2.00 to 8.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, Evexia Lifecare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Consumer Packaged Goods company?
The median Piotroski F-Score among Consumer Packaged Goods companies is 5.00, based on 1,912 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Evexia Lifecare's current Piotroski F-Score of 6 is 20% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Evexia Lifecare and its competitors. For the Consumer Packaged Goods industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Evexia Lifecare's current Piotroski F-Score is 6, which is near median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evexia Lifecare stock overvalued right now?
Based on GuruFocus' analysis, Evexia Lifecare (BOM:524444) is currently considered Fairly Valued. The stock's GF Value™ is ₹1.59, compared to a current price of ₹1.59 — trading right at its estimated fair value. The current Piotroski F-Score is 6, which is near median its 10-year median of 6.00 and 20% above the Consumer Packaged Goods industry median of 5.00. Evexia Lifecare's overall GF Score™ is 64/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Evexia Lifecare (BOM:524444), the current Piotroski F-Score is 6 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Evexia Lifecare (BOM:524444) Overvalued in 2026?
Based on GuruFocus' analysis, Evexia Lifecare stock appears to be undervalued.
The current stock price of ₹1.59 is trading 0% below its estimated GF Value™ of ₹1.59.
GuruFocus considers Evexia Lifecare to be Fairly Valued.
Key valuation signals for BOM:524444:
Piotroski F-Score: 6 (near median its 10-year median of 6.00)
GF Value™: ₹1.59 vs. price of ₹1.59 (0% below fair value)
Industry Position: 20% above the Consumer Packaged Goods median (#510 of 1912)
No single metric tells the full story. See the BOM:524444 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Evexia Lifecare Ltd diversified healthcare company specializing in the trading of pharmaceutical chemicals, retail pharmacy services, diagnostic solutions, and personal healthcare products, committed to improving well-being with quality and reliability.
64GF Score
Get the complete analysis for BOM:524444
Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524444 has been successfully added to your 
